Protara Therapeutics (TARA) announced that data from THRIVE-1, a prospective, observational study evaluating the prevalence of choline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback